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Abstract
Background: Loss of integrity of the epithelial and endothelial barriers is thought to be a prominent feature of ventilator-
induced lung injury (VILI). Based on its function in vascular integrity, we hypothesize that the angiopoietin (Ang)-Tie2
system plays a role in the development of VILI. The present study was designed to examine the effects of mechanical
ventilation on the Ang-Tie2 system in lung tissue. Moreover, we evaluated whether treatment with Ang-1, a Tie2 receptor
agonist, protects against inflammation, vascular leakage and impaired gas exchange induced by mechanical ventilation.
Methods: Mice were anesthetized, tracheotomized and mechanically ventilated for 5 hours with either an inspiratory
pressure of 10 cmH2O (‘low’ tidal volume ,7.5 ml/kg; LVT) or 18 cmH2O (‘high’ tidal volume ,15 ml/kg; HVT). At initiation
of HVT-ventilation, recombinant human Ang-1 was intravenously administered (1 or 4 mg per animal). Non-ventilated mice
served as controls.
Results: HVT-ventilation influenced the Ang-Tie2 system in lungs of healthy mice since Ang-1, Ang-2 and Tie2 mRNA were
decreased. Treatment with Ang-1 increased Akt-phosphorylation indicating Tie2 signaling. Ang-1 treatment reduced
infiltration of granulocytes and expression of keratinocyte-derived chemokine (KC), macrophage inflammatory protein
(MIP)-2, monocyte chemotactic protein (MCP)-1 and interleukin (IL)-1b caused by HVT-ventilation. Importantly, Ang-1
treatment did not prevent vascular leakage and impaired gas exchange in HVT-ventilated mice despite inhibition of
inflammation, vascular endothelial growth factor (VEGF) and Ang-2 expression.
Conclusions: Ang-1 treatment downregulates pulmonary inflammation, VEGF and Ang-2 expression but does not protect
against vascular leakage and impaired gas exchange induced by HVT-ventilation.
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Introduction
Mechanical ventilation is an important life-saving procedure.
However, the procedure itself may induce or aggravate damage to
lung tissue, so-called ventilator-induced lung injury (VILI) [1,2].
VILI is characterized by inflammation, enhanced alveolar-
capillary membrane permeability, accumulation of protein-rich
pulmonary edema and ultimately impaired gas exchange [3].
Various animal models have been used to obtain further insight
into the mechanisms underlying VILI. Already in the 1980s,
investigators showed that mechanical ventilation and the subse-
quent mechanical (over)stretch of lung tissue induces damage to
the epithelial-endothelial barrier leading to impaired oxygenation
[4–6]. In addition, it has been described that the mechanical forces
associated with mechanical ventilation provoke an inflammatory
response in the lung (biotrauma) [7,8].
Loss of integrity of epithelial and endothelial cell monolayers
has been suggested to play an important role in the ventilator-
induced disruption of the alveolar-capillary barrier [9]. One of the
crucial systems regulating vascular cell integrity is the angiopoietin
(Ang)-Tie2 system [10]. Clarifying the role of the Ang-Tie2 system
in the development of lung injury has therefore become a topic of
great interest [11]. However, to date little is known about the
interaction of mechanical (over)stretch with the Ang-Tie2 system.
It has been recognized that Ang-1 serves as a Tie2 receptor agonist
by phosphorylating Tie2 on tyrosine residues. Ang-12mediated
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quiescence of the endothelial barrier [10]. The antagonist Ang-2 is
known to downregulate Tie2 signaling, thereby preparing vascular
endothelial cells for enhanced responsiveness to factors that cause
destabilization of the endothelial barrier [12]. However, there is
also conflicting evidence that Ang-2 may cause Tie2 activation in
stressed endothelial cells [13].
In a murine model of endotoxin-induced acute lung injury
(ALI), Karmpaliotis et al. described that vascular permeability and
pulmonary edema were accompanied by enhanced vascular
endothelial growth factor (VEGF) and reduced Ang-1 levels in
lung tissue [14]. The same authors proposed that changes in the
balance between VEGF (pro-leakage) and Ang-1 (anti-leakage)
might contribute to the pathophysiology of ALI. Protective effects
of Ang-1 treatment have been shown before in experimental
models of endotoxin-induced ALI [15–18]. Mei et al. demonstrat-
ed that treatment with Ang-1 attenuated vascular leakage,
granulocyte infiltration and pro-inflammatory cytokine expression
in lungs of endotoxin-exposed mice [17]. Consequently, the Ang-
Tie2 system has been proposed as a possible therapeutic target in
pulmonary diseases like ALI and its most severe form, the acute
respiratory distress syndrome (ARDS) [11,19].
Vascular leakage and pulmonary inflammation are important
features of VILI. Therefore, we hypothesized that Ang-12Tie2
signaling plays a (protective) role in the development of VILI. In an
attempt to better reflect the human setting, we applied a relatively
mild model of VILI using clinically relevant ventilator settings
thereby preventing shock, metabolic acidosis and substantial
damage to lung architecture [20]. The aim of present study was
to investigate the influence of mechanical ventilation on the Ang-
Tie2 system in lungs of healthy adult mice. Furthermore, we
examined whether treatment with Ang-1, a Tie2 receptor agonist,
would protect ventilated mice against important hallmarks of VILI
such as inflammation, vascular leakage and impaired gas exchange.
Methods
Animals
Experiments were performed in accordance with international
guide lines and approved by the animal care and use committees
of the University Medical Center Utrecht and the Academic
Medical Center Amsterdam (approval IDs: 2007.II.02.066 and
DAA101607). Adult male C57Bl6 mice (n=145; Charles River,
Maastricht, the Netherlands), weighing 20 to 24 grams, were
randomly assigned to different experimental groups.
Mice (n=114) were ventilated for 5 hours as described
previously [20]; pressure-controlled, fractional inspired oxygen
concentration (FiO2) of 0.5, inspiration-to-expiration ratio of 1:1
and positive end-expiratory pressure of 2 cmH2O. Six mice were
ventilated simultaneously with either an inspiratory pressure of
10 cmH2O (resulting in ‘low’ tidal volume (VT) ,7.5 ml/kg; LVT)
or 18 cmH2O (resulting in ‘high’ VT ,15 ml/kg; HVT).
Respiratory rate was set at 100 and 50 breaths/min, respectively.
Body temperature was kept constant between 36.5 and 37.5uC.
Non-ventilated mice (n=31) served as controls (non-ventilated
controls, NVC).
Ang-1 treatment
At initiation of HVT-ventilation, recombinant human Ang-1
(carrier free; R&D systems, Minneapolis, MN) was intravenously
administered (either 1 or 4 mg per animal). The dose of 1 mg has
been shown to be efficient in attenuating lung inflammation and
injury [21]. Control HVT-ventilated mice received the same
volume of sterile saline (vehicle) intravenously.
Hemodynamics and blood gas analysis
After 0, 2.5 and 5 hours, systolic blood pressure and heart rate
were non-invasively monitored using a tail-cuff system (ADInstru-
ments, Spenbach, Germany). After 5 hours, arterial blood was
taken from the carotid artery for blood gas analysis (Rapidlab 865;
Bayer, Mijdrecht, the Netherlands).
Bronchoalveolar lavage
The right lung was lavaged by instilling 360.5 ml sterile saline.
Differential counts were done on cytospin preparations stained
with Giemsa (Diff-Quick; Dade Behring AG, Du ¨dingen, Switzer-
land). Cell-free supernatant was used to measure total protein
(BCA protein-assay; Pierce Biotechnology, Rockford, IL) with
BSA as standard.
Wet-to-dry ratio
The left lung was weighed, dried for 3 days (65uC) and weighed
again.
Histology and immunohistochemistry
The left lung was filled with Tissue-TekH (Sakura Finetek,
Zoeterwoude, the Netherlands), snap frozen and cut to 5 mm
cryosections using a cryostat. To assess pulmonary histopathology,
sections were stained with hematoxylin-eosin (H&E; Klinipath,
Duiven, the Netherlands). To assess Tie2 localization, sections
were stained with fluorescent antibody recognizing Tie2 (Tek4;
eBioscience, San Diego, CA) or isotype control antibody (IgG1-
biotin).
Tissue homogenate preparation
Lung tissue of separate animals were pulverized using a liquid
nitrogen-cooled mortar and pestle, and divided in several fractions
allowing us to perform multiple analyses (as described below).
Real-time RT-PCR analysis
PCR was performed as described previously [22]. Primer
sequences: Ang-1, forward CTACCAACAACAACAgCATCC,
reverse CTCCCTTTAgCAAAACACCTTC; Ang-2, forward
CTgTgCggAAATCTTCAAgTC, reverse TgCCATCTTCTCgg-
TgTT; Tie2, forward gTgTAgTggACCAgAAgg, reverse CTTgA-
gAgCAgAggCATC. Data were normalized for expression of
internal controls, i.e. the average value of b-actin and glyceralde-
hyde 3-phosphate dehydrogenase (GAPdH).
Western blotting
Western blotting was performed as described previously [23].
Antibodies recognized phospho (p)-Akt (Ser473; Cell Signaling,
Danvers, MA), Ang-1 or Ang-2 (both Alpha Diagnostic, San
Antonio, TX). To control for equal loading, membranes were
stripped when necessary and reprobed with an antibody
recognizing total Akt (Akt1/PKBa; Sigma-Aldrich, Steinheim,
Germany). Total Akt was chosen as a loading control since
mechanical ventilation influenced expression levels of b-actin in
our experimental model of VILI.
ELISA
Tie2 protein was measured by ELISA according to manufac-
turer’s instructions (R&D).
Myeloperoxidase (MPO) activity
MPO activity was determined as described previously [22].
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125 mg protein was analyzed for keratinocyte-derived chemo-
kine (KC), macrophage inflammatory protein (MIP)-2, monocyte
chemotactic protein (MCP)-1, interleukin (IL)-1b, IL-6, IL-10 and
VEGF by multiplex cytokine assay using a Luminex analyzer (Bio-
Rad Laboratories, Hercules, CA) according to manufacturer’s
instructions (multiplex mouse cytokine, R&D).
Statistical analysis
Data are expressed as mean 6 SEM. Oxygenation variables
(LVT versus HVT) and Ang-1, Ang-2, Tie2 protein (NVC versus
HVT) were analyzed by independent T-test. Other parameters
were analyzed by one-way ANOVA with least significant
difference (LSD) post-hoc test. P-values less than 0.05 were
considered statistically significant.
Results
Stability of the murine model of VILI
All mice survived 5 hours of LVT and HVT-ventilation after
which they were sacrificed. Analysis of systolic blood pressure and
heart rate revealed stable conditions of ventilated mice throughout
the experiment (table 1).
Table 2 illustrates that arterial oxygen tension (PaO2) was
reduced in HVT-ventilated mice when compared to LVT-
ventilated mice. Carbon dioxide tension (PaCO2), pH and base
excess (BE) remained within the physiological range during both
LVT and HVT-ventilation.
Effect of mechanical ventilation on alveolar-capillary
permeability, pulmonary edema formation and gas
exchange
First, we examined whether LVT and HVT-ventilation caused
lung injury in mice without pre-existing lung injury. Total protein
levels in bronchoalveolar lavage fluid (BALf), wet-to-dry ratios of
pulmonary tissue and PaO2/FiO2 ratio in blood samples were
analyzed to evaluate the effects of mechanical ventilation on
alveolar-capillary permeability, pulmonary edema formation and
gas exchange respectively. We found that both ventilation
strategies markedly enhanced BALf protein levels and pulmonary
wet-to-dry ratios in comparison with NVC (figures 1a and b).
Furthermore, PaO2/FiO2 ratios were significantly decreased when
comparing HVT-ventilated mice with LVT-ventilated mice
(figure 1c).
Effect of mechanical ventilation on the Ang-Tie2 system
To assess whether 5 hours of mechanical ventilation influenced
the Ang-Tie2 system, we determined Ang-1, Ang-2 and Tie2
expression in total lung homogenates. We found that only HVT-
ventilation caused a decrease in Ang-1 and Ang-2 mRNA
compared to NVC (figures 2a and b). Both ventilation strategies
reduced Tie2 mRNA (figure 2c). Since ventilator-induced effects
on the Ang-Tie2 system, vascular leakage and oxygenation were
most pronounced after HVT-ventilation, we continued our
investigations by focusing on this specific group.
To determine if ventilator-induced reduction of Ang-1, Ang-2
and Tie2 mRNA also resulted in a reduction of Ang-1, Ang-2 and
Tie2 protein, we measured protein expression of these mediators
in total lung homogenates. Decreased Ang-1 and Ang-2 protein
levels were observed after 5 hours of HVT-ventilation, although
these differences did not reach statistical significance (p=0.084
and p=0.058 respectively, figures 2d and e). In addition, HVT-
ventilation did not lead to downregulation of Tie2 protein
expression (figure 2f). To evaluate the localization of Tie2 in
pulmonary tissue, Tie2 protein was visualized by immunofluores-
cent staining on lung sections of NVC. As illustrated in figure 2g,
Tie2 was primarily detected in larger arterioles and alveolar-
capillary membranes (isotype control was negative).
Effect of Ang-1 treatment on phospho-Akt (p-Akt), Ang-2
and VEGF expression
Mice were treated with either sterile saline (vehicle), 1 mg Ang-1
or 4 mg Ang-1 per animal at initiation of HVT-ventilation and
subsequently ventilated for 5 hours. No changes in hemodynamic
and blood gas variables were observed after Ang-1 treatment (data
not shown). We determined the level of p-Akt protein. Akt
phosphorylation is known to be induced by Ang-1–mediated Tie2
signaling, and thus, increased levels of p-Akt may serve as indirect
evidence of Tie2 receptor activation. HVT-ventilation induced
phosphorylation of Akt compared to NVC and Ang-1 treatment
enhanced the level of p-Akt even further (figure 3). This increase
was most distinct when using a dose of 4 mg Ang-1 per animal.
We also studied if Ang-1 treatment altered the expression of
factors promoting vascular leakage like Ang-2 and VEGF. On
mRNA level, Ang-2 expression was downregulated in lungs of
HVT-ventilated mice treated with 1 or 4 mg Ang-1 (figure 4a). At
this time point, no effect of Ang-1 treatment was observed on Ang-
2 protein expression (figure 4b). Compared to NVC, VEGF
protein expression was increased in the vehicle-treated HVT-group
(figure 5). Both doses of Ang-1 completely abolished the increase in
VEGF protein in response to HVT-ventilation.
Table 1. Hemodynamic characteristics over 5 hours of
mechanical ventilation.
LVT HVT
HR t=0hr 370611 387617
HR t=2,5hr 382611 336613
HR t=5hr 403612 35169
BP t=0hr 104649 7 66
BP t=2,5hr 76667 2 64
BP t=5hr 73657 4 65
LVT,H V T = mice ventilated with low or high tidal volumes; HR = heart rate in
beats per minute, BP = systolic blood pressure in mmHg. Data are presented as
mean 6 SEM of 11 to 12 animals per group.
doi:10.1371/journal.pone.0015653.t001
Table 2. Arterial blood gas analysis after 5 hours of
mechanical ventilation.
LVT HVT
PaO2 231.6615.8 165.8612.8*
PaCO2 32.463.4 35.162.5
pH 7.5160.03 7.5060.02
BE 2.0860.78 3.5460.91
LVT,H V T = mice ventilated with low or high tidal volumes; PaO2 = partial
pressure of arterial oxygen in mmHg; PaCO2 = partial pressure of arterial
carbon dioxide in mmHg; BE = base excess in mmol/l. Data are presented as
mean 6 SEM of 16 to 18 animals per group (*p,0.01 versus LVT).
doi:10.1371/journal.pone.0015653.t002
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capillary permeability is represented by total protein levels in bronchoalveolar lavage fluid (BALf). B: Pulmonary edema is represented by wet-to-dry
ratios of lung tissue. C: Oxygenation is represented by the ratio of partial pressure arterial oxygen and fraction inspired oxygen (PaO2/FiO2). Data are
expressed as mean 6 SEM of 9-12 (A–B) or 18–21 (C) animals for each group (* p,0.05, *** p,0.001). Ref = reference bar (PaO2/FiO2 ratio for mice
with non-injured lungs); NVC = non-ventilated controls; LVT,H V T = mice ventilated with low or high tidal volumes.
doi:10.1371/journal.pone.0015653.g001
Figure 2. Mechanical ventilation affects the angiopoietin (Ang)-Tie2 system. A–C: In total lung homogenates, mRNA expression of Ang-1,
Ang-2 and Tie2 was determined by real time RT-PCR. Levels were normalized for expression of internal controls, i.e. the average value of b-actin and
glyceraldehyde 3-phosphate dehydrogenase (GAPdH). No group differences in expression levels of b-actin and GAPdH were observed. D–E: In total
lung homogenates, protein expression of Ang-1 and Ang-2 was determined by Western blotting. Membranes were reprobed with antibody
recognizing total Akt (Akt1/PKBa) to control for equal loading. No group differences in total Akt were observed. Inset: representative Western Blot
depicting immunodetectable Ang-1 and Ang-2. F: In total lung homogenates, protein expression of Tie2 was determined by ELISA. Levels were
normalized for total protein concentrations. Data are depicted relative to NVC and expressed as mean 6 SEM of 6–16 animals for each group
(** p,0.01, *** p,0.001). G: Lung sections of non-ventilated controls were stained with fluorescent antibody recognizing Tie2 to visualize the
presence of Tie2 on pulmonary cells (isotype control was negative). Magnification6200. NVC = non-ventilated controls; LVT,H V T = mice ventilated
with low or high tidal volumes.
doi:10.1371/journal.pone.0015653.g002
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granulocyte infiltration in pulmonary tissue and
granulocyte exudation into the alveolar space
To determine the effect of Ang-1 treatment on inflammatory activity
in the lung, we first quantified granulocyte infiltration by measuring
MPO activity in total lung homogenates and by counting neutrophils
on BALf cytospin preparations. Compared to NVC, MPO activity and
neutrophil numbers were markedly higher in lungs of HVT-ventilated
mice (figures 6a and b). Administration of either 1 or 4 mgA n g - 1
reduced granulocyte influx after HVT-ventilation (figure 6a). Support-
ing the MPO data, neutrophil numbers on BALf cytospin preparations
were diminished in HVT-ventilated mice treated with 1 mgA n g - 1a s
compared to HVT-ventilated mice treated with vehicle (figure 6b). In
addition, we stained lung sections for H&E to visualize granulocytes in
pulmonary tissue. Figure 6c illustrates that both doses of Ang-1
prevented the appearance of granulocytes in lungs of HVT-ventilated
mice, confirming the quantitative measures for infiltrating granulocytes.
Effect of Ang-1 treatment on ventilator-induced
chemokine and cytokine expression
The effect of Ang-1 treatment on the levels of inflammatory
mediators expressed by pulmonary tissue during HVT-ventilation was
determined as an additional measure of inflammatory activity in the
lung. HVT-ventilation induced protein expression of the chemokines
KC, MIP-2 and MCP-1 in comparison with NVC (figures 7a to c).
Consistent with the diminished granulocyte influx, treatment with
either 1 or 4 mg Ang-1 reduced the upregulation of these chemokines
after 5 hours of HVT-ventilation. Moreover, higher levels of the pro-
inflammatory cytokine IL-1bwere found in pulmonary tissue of HVT-
ventilated mice (figure 7d). The elevated protein expression of IL-6 did
not reach statistical significance (p=0.064, figure 7e). Although Ang-1
treatment decreased the expression of IL-1b protein compared to the
HVT-vehicle group, it did not influence the expression of IL-6
Figure 3. Angiopoietin (Ang)-1 treatment induces Tie2 signal-
ing. In total lung homogenates, protein expression of p-Akt was
determined by Western blotting as an indirect measure of Tie2
signaling. Membranes were stripped and reprobed with antibody
recognizing total Akt (Akt1/PKBa) to control for equal loading. No
group differences in total Akt were observed. Inset: representative
Western blot depicting immunodetectable p-Akt. Data are depicted
relative to NVC and expressed as mean 6 SEM of 8–10 animals per
group (* p,0.05, ** p,0.01). NVC = non-ventilated controls; HVT =
mice ventilated with high tidal volumes; Veh, 1 mg, 4 mg = mice
intravenously treated with either vehicle (sterile saline), Ang-1 (1 mg per
animal), or Ang-1 (4 mg per animal).
doi:10.1371/journal.pone.0015653.g003
Figure 4. Angiopoietin (Ang)-1 treatment reduces Ang-2 mRNA expression. A: In total lung homogenates, mRNA expression of Ang-2 was
determined by real time RT-PCR. Levels were normalized for expression of internal controls, i.e. the average value of b-actin and glyceraldehyde 3-
phosphate dehydrogenase (GAPdH). No group differences in b-actin and GAPdH were observed. B: In total lung homogenates, protein expression of
Ang-2 was determined by Western blotting. Membranes were reprobed with antibody recognizing total Akt (Akt1/PKBa) to control for equal loading.
No group differences in total Akt were observed. Inset: representative Western blot depicting immunodetectable Ang-2. Data are depicted relative to
NVC and expressed as mean 6 SEM of 7–16 animals per group (** p,0.01, *** p,0.001). NVC = non-ventilated controls; HVT = mice ventilated with
high tidal volumes; Veh, 1 mg, 4 mg = mice intravenously treated with either vehicle (sterile saline), Ang-1 (1 mg per animal), or Ang-1 (4 mg per
animal).
doi:10.1371/journal.pone.0015653.g004
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detection level in all experimental groups.
Effect of Ang-1 treatment on ventilator-induced lung
injury
Ang-1 treatment suppressed the inflammatory activity in the
lung. To determine the consequences for lung injury, we evaluated
whether the increase in vascular leakage and decrease in
oxygenation during HVT-ventilation could be restored by Ang-1
administration. As depicted in figures 8a and b, the increased
BALf protein levels and pulmonary wet-to-dry ratios of HVT-
ventilated mice were not affected by treatment with either 1 or
4 mg Ang-1. Furthermore, both doses of Ang-1 did not prevent the
reduction in PaO2/FiO2 ratio caused by HVT-ventilation
(figure 8c).
Discussion
At the best of our knowledge this is the first report
demonstrating that mechanical ventilation affects the Ang-Tie2
system in pulmonary tissue of healthy adult mice. Particularly in
lungs of HVT-ventilated mice, we observed marked changes in the
Ang-Tie2 system. Compared to NVC, 5 hours of HVT-ventilation
resulted in downregulation of Ang-1, Ang-2 and Tie2 mRNA
expression. In addition, Ang-1 and Ang-2 protein expression
tended to decrease in HVT-ventilated mice at this time point. The
Figure 6. Angiopoietin (Ang)-1 treatment reduces granulocyte infiltration. A: In total lung homogenates, myeloperoxidase (MPO) activity
was determined as a measure of granulocyte infiltration. Levels were normalized for total protein concentrations. No group differences in tissue total
protein were observed. B: On cytospin preparations, differential cell counts were done to determine neutrophil exudation in the alveolar space. Data
are depicted relative to NVC and expressed as mean 6 SEM of 5–16 animals per group (* p,0.05, *** p,0.001). C: Lung sections were stained with
hematoxylin-eosin (H&E) to analyze the presence of granulocytes in pulmonary tissue. Magnification 6500. NVC = non-ventilated controls; HVT =
mice ventilated with high tidal volumes; Veh, 1 mg, 4 mg = mice intravenously treated with either vehicle (sterile saline), Ang-1 (1 mg per animal), or
Ang-1 (4 mg per animal).
doi:10.1371/journal.pone.0015653.g006
Figure 5. Angiopoietin (Ang)-1 treatment reduces vascular
endothelial growth factor (VEGF) protein expression. In total
lung homogenates, protein expression of VEGF was determined by
multiplex cytokine analysis. Levels were normalized for total protein
concentrations. No group differences in tissue total protein were
observed. Data are depicted relative to NVC and expressed as mean 6
SEM of 8–10 animals (* p,0.05, *** p,0.001). NVC = non-ventilated
controls; HVT = mice ventilated with high tidal volumes; Veh, 1 mg,
4 mg = mice intravenously treated with either vehicle (sterile saline),
Ang-1 (1 mg per animal), or Ang-1 (4 mg per animal).
doi:10.1371/journal.pone.0015653.g005
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affected only specific aspects of VILI. Ang-1 administration at
initiation of ventilation diminished granulocyte infiltration, as well
as chemokine (KC, MIP-2, MCP-1), cytokine (IL-1b), VEGF and
Ang-2 expression in lungs of HVT-ventilated mice. However, Ang-
1 treatment did not prevent the increase in BALf protein level, the
increase in pulmonary wet-to-dry ratio and the reduction in
PaO2/FiO2 ratio induced by HVT-ventilation. This result was not
only observed after administration of 1 mg of Ang-1 but also after
administration of 4 mg of Ang-1. In preliminary experiments we
also investigated whether a higher dose of Ang-1 (i.e. 8 mg per
animal) would influence alveolar-capillary permeability and
pulmonary edema formation induced by mechanical ventilation.
However, 8 mg of Ang-1 appeared to have no effect on ventilator-
induced vascular leakage as well. In view of these data, we would
like to suggest that Ang-1 treatment does not prevent the aspects of
VILI driven by mechanosensitive alterations in barrier properties
[24] but will only regulate the pulmonary inflammation.
In experimental studies, mechanical ventilation has been
described to induce destabilization of the alveolar-capillary barrier
thereby leading to enhanced pulmonary permeability and edema
formation [4-6]. Most models of VILI, however, applied very high
inspiratory pressures or tidal volumes when compared to those used
in the human setting [25-29]. To prevent shock and metabolic
acidosis due to very high inspiratory pressures or tidal volumes, we
used ventilation strategies with more clinically relevant ventilator
settings [20]. Even in this relatively mild model of VILI, we observed
that mechanical ventilation caused a modest, but significant increase
in BALf protein level and pulmonary wet-to-dry ratio.
The importance of the Ang-Tie2 system has been appreciated
in the development of vascular leakage and inflammation in
pulmonary diseases like ALI/ARDS [11]. In this respect,
Karmpaliotis et al. proposed that changes in the balance between
VEGF (pro-leakage) and Ang-1 (anti-leakage) might contribute to
vascular leakage in their murine model of lipopolysaccharide
(LPS)-induced ALI [14]. Here we demonstrate that HVT-
ventilation as such enhanced expression of VEGF protein,
decreased expression of Ang-1, Ang-2 and Tie2 mRNA and
tended to reduce expression of Ang-1 and Ang-2 protein
compared to NVC. Since the mice were sacrificed after 5 hours
Figure 7. Angiopoietin (Ang)-1 treatment reduces chemokine and interleukin (IL)-1b protein expression. A–E: In total lung
homogenates, protein expression of the chemo-attractants keratinocyte-derived chemokine (KC), macrophage inflammatory protein (MIP)-2,
monocyte chemotactic protein (MCP)-1 and the pro-inflammatory cytokines IL-1b, IL-6 was determined by multiplex cytokine analysis. Data are
depicted relative to NVC and expressed as mean 6 SEM of 8–10 animals per group (* p,0.05, ** p,0.01, *** p,0.001). NVC = non-ventilated
controls; HVT = mice ventilated with high tidal volumes; Veh, 1 mg, 4 mg = mice intravenously treated with either vehicle (sterile saline), Ang-1 (1 mg
per animal), or Ang-1 (4 mg per animal).
doi:10.1371/journal.pone.0015653.g007
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ulation in mRNA expression was followed by a significant decrease
in protein expression at a later time point. Even so, the present
study suggests that alterations in the Ang-Tie2 system are involved
in the pathogenesis of VILI.
Kim et al. and Papapetropoulos et al. have demonstrated that
Ang-12mediated Tie2 signaling causes Akt phosphorylation
thereby protecting the endothelial cells from apoptotic cell death
[30,31]. In our study, HVT-ventilation itself caused increased p-
Akt levels compared to NVC which is in agreement with previous
reports [32,33]. Moreover, treatment with Ang-1 augmented p-
Akt expression in lungs of HVT-ventilated mice. (Ang-12mediat-
ed) Akt phosphorylation has been shown to inactivate the forkhead
transcription factor FKHR1 subsequently preventing Ang-2
expression and destabilization of the endothelial barrier [34].
This observation supports our finding that HVT-ventilation as
such reduced Ang-2 mRNA and that Ang-1 treatment downreg-
ulated the transcription of Ang-2 even further. The Ang-
12induced shift towards less Ang-2 production, thus reduced
Tie2 antagonism, may protect against lung inflammation and
injury during HVT-ventilation.
In agreement with previous reports [27-29], we observed that
ventilator-induced lung injury was accompanied by enhanced pro-
inflammation. In LPS-challenged animals, treatment with Ang-1
has already been shown to decrease leukocyte trafficking by
reducing chemotactic, adhesive and pro-inflammatory mediators
[17]. Our study is the first to show that Ang-1 administration
downregulated infiltration of granulocytes and expression of the
chemokines KC, MIP-2 and MCP-1 in an experimental model of
VILI. Furthermore, we observed that administration of Ang-1
prevented the increase in the pro-inflammatory cytokine IL-1b in
lungs of HVT-ventilated mice. Our data may suggest that the role
of IL-1b might be less important in the development of vascular
leakage during HVT- ventilation. Interestingly, IL-6 protein levels
remained high in lungs of HVT-ventilated mice despite Ang-1
treatment. In pulmonary inflammation, IL-1b is primarily
produced by activated alveolar macrophages whereas IL-6 may
be derived from a wide variety of pulmonary cell types [35]. Since
Tie2 is expressed on endothelial cells, neutrophils and macro-
phages [36,37], our observations may imply that IL-6 is also
derived from cells that do not express the Tie2 receptor and
consequently do not respond to Ang-1. With respect to the clinical
situation, it would be of interest to evaluate whether Ang-1
treatment would also be effective in attenuating lung inflammation
in ventilated animals with pre-existing lung inflammation.
The angiogenic growth factor VEGF has been shown to increase
capillary permeability and edema formation in various experimen-
tal models of pulmonary injury, including VILI [14,38,39].
Thurston et al. described that vascular leakage induced by VEGF
may be counteracted by Ang-1 [40,41]. In line with this notion, we
observed that Ang-1 treatment completely abolished the increase in
VEGF protein in lungs of HVT-ventilated mice. Nonetheless, it
should be noted that Ang-1 treatment did not prevent alveolar-
capillary permeability, pulmonary edema (i.e. vascular leakage) and
impaired gas exchange induced by HVT-ventilation. These data are
in apparent contrast with previously described protective effects of
Ang-1 on vascular leakage in endotoxin-challenged animals [15-18]
underlining that the pathways involved in endotoxin- and
ventilator-induced lung injury are different. An explanation for this
discrepancy might be that the enhanced inflammation is not the
primary inducer of vascular leakage and impaired gas exchange
duringHVT-ventilation, as is the case in the inductionof lung injury
by LPS. It has been demonstrated that ventilator-induced
mechanical stretch may also lead to the destabilization of
alveolar-epithelial and capillary-endothelial barriers thereby result-
ing in increased vascular permeability and pulmonary edema [4-6].
Ang-1 administration will probably influence the capillary-endo-
thelial but not the alveolar-epithelial barrier since the Tie2 receptor
is mainly expressed on endothelial cells. Thus, the possibility
remains that Ang-1 treatment is not capable of restoring lung injury
induced by HVT-ventilation as it only modulates endothelial
inflammation. The fact that Ang-1 prevents pulmonary vascular
leakage in animals exposed to LPS, which induces a generalized
inflammation primarily in the endothelial cells of the lung [42],
supports this hypothesis.
Taken together, our data indicate that treatment with Ang-1
inhibits various aspects of VILI such as granulocyte infiltration,
chemokine/cytokine and VEGF expression. However, Ang-1
Figure 8. Angiopoietin (Ang)-1 treatment does not prevent alveolar-capillary permeability, pulmonary edema formation and
impaired gas exchange. A: Alveolar-capillary permeability is represented by total protein levels in bronchoalveolar lavage fluid (BALf). B:
Pulmonary edema is represented by wet-to-dry ratios of lung tissue. C: Oxygenation is represented by the ratio of arterial oxygen partial pressure to
fractional inspired oxygen concentration (PaO2/FiO2). Data are expressed as mean 6 SEM of 5-15 (A–B) or 14–18 (C) animals per group (*** p,0.001).
Ref = reference bar (PaO2/FiO2 ratio for mice with non-injured lungs); NVC = non-ventilated controls; HVT = mice ventilated with high tidal volumes;
Veh, 1 mg, 4 mg.= mice intravenously treated with either vehicle (sterile saline), Ang-1 (1 mg per animal), or Ang-1 (4 mg per animal).
doi:10.1371/journal.pone.0015653.g008
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crude parameters of VILI (i.e. vascular leakage and impaired gas
exchange). In this respect, it is of interest that the TNF-a inhibitor
Etanercept diminished inflammation and coagulation in the lungs
of ventilated mice without influencing alveolar-capillary perme-
ability and pulmonary edema, which is in line with our present
results [43]. We propose that Ang-1 should not be applied to
combat the mechanosensitive aspects of ventilator-induced lung
injury in critically ill patients. Nonetheless, treatment with Ang-1
may well be considered as an anti-inflammatory therapy when
inflammation is the primary inducer of lung injury, like in non-
ventilated patients diagnosed with ALI/ARDS.
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